Angiopep NK Vesicles Delivered Temozolomide in Glioblastoma Mice
TL;DR: A 2026 study in Journal of Nanobiotechnology found that Angiopep-2-modified natural killer cell extracellular vesicles carried temozolomide across glioblastoma barriers, reduced mouse tumor bioluminescence, and extended median survival in an orthotopic GBM model. Key Findings 2.5-3.2x uptake: Angiopep-2 modification increased glioblastoma-cell uptake of NK extracellular vesicles compared with unmodified NK-EV. 2.8-3.5x BBB transport: Ang-NK-EV@TMZ …
